- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, February 23, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in Fierce Healthcare referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Potential Inequities in Access to In-Person SHIP Counseling Services,” found that 13.2% of localities did not have a nearby State Health Insurance Assistance Program (SHIP).
An article from Nation World News referenced a podcast published on AJMC.com, the website of AJMC. The podcast, “Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans,” featured the authors of the study “Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans,” published in the February 2024 issue of AJMC, to discuss their findings and how health plans can screen for health literacy.
A study entitled, “Characterizing Telehealth Use in the US: Analysis of the 2022 Health Information National Trends Survey,” published in the January 2024 issue of AJMC, was referenced in an article from Psychiatric Times. The study determined that identifying the motivation behind a patient’s use of telehealth could help to understand the value of telehealth services.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy
August 15th 2025Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression after CAR T-cell therapy, highlighting treatment challenges and outcomes.
Read More
